Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Marimed (MRMD) EBT Margin (2016 - 2025)

Marimed has reported EBT Margin over the past 15 years, most recently at 17.59% for Q4 2025.

  • Quarterly EBT Margin fell 908.0% to 17.59% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 6.67% through Dec 2025, down 413.0% year-over-year, with the annual reading at 6.8% for FY2025, 409.0% down from the prior year.
  • EBT Margin was 17.59% for Q4 2025 at Marimed, down from 0.45% in the prior quarter.
  • Over five years, EBT Margin peaked at 35.01% in Q2 2021 and troughed at 24.76% in Q4 2023.
  • The 5-year median for EBT Margin is 1.76% (2021), against an average of 4.25%.
  • Year-over-year, EBT Margin surged 5351bps in 2021 and then crashed -3245bps in 2023.
  • A 5-year view of EBT Margin shows it stood at 2.47% in 2021, then soared by 211bps to 7.69% in 2022, then crashed by -422bps to 24.76% in 2023, then surged by 66bps to 8.51% in 2024, then tumbled by -107bps to 17.59% in 2025.
  • Per Business Quant, the three most recent readings for MRMD's EBT Margin are 17.59% (Q4 2025), 0.45% (Q3 2025), and 1.46% (Q2 2025).